Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-08-09 Option Award |
2021-08-09 5:34 pm |
N/A 2031-08-08 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 5:16 pm |
N/A 2031-06-15 |
Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:01 pm |
N/A 2031-06-15 |
Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:01 pm |
N/A 2031-06-15 |
Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:01 pm |
N/A 2031-06-15 |
Trevi Therapeutics Inc. | TRVI | Cassella James V Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:00 pm |
N/A 2031-06-15 |
Trevi Therapeutics Inc. | TRVI | Colangelo Dominick Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:00 pm |
N/A 2031-06-15 |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-04-13 Option Award |
2021-04-15 7:04 pm |
N/A 2031-04-12 |
Trevi Therapeutics Inc. | TRVI | Galletta Christopher See Remarks |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 4:15 pm |
N/A 2031-02-16 |
Trevi Therapeutics Inc. | TRVI | Seiter Christopher Chief Financial Officer |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 4:15 pm |
N/A 2031-02-16 |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
160,000 | $0 | 160,000 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 4:15 pm |
N/A 2031-02-16 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 4:15 pm |
N/A 2031-02-16 |
Trevi Therapeutics Inc. | TRVI | Muscolo Frank P Controller |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 4:20 pm |
N/A 2031-01-31 |
Trevi Therapeutics Inc. | TRVI | Forbes William P Chief Development Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2020-06-29 Option Award |
2020-07-01 5:58 pm |
N/A 2030-06-28 |
Trevi Therapeutics Inc. | TRVI | Colangelo Dominick Director |
23,684 | $0 | 23,684 (Direct) |
View |